|
CN100444843C
(zh)
*
|
1998-08-10 |
2008-12-24 |
旭化成制药株式会社 |
法舒地尔盐酸盐缓释口服制剂
|
|
US20030060487A1
(en)
*
|
2000-04-12 |
2003-03-27 |
Bamdad R. Shoshana |
Treatment of neurodegenerative disease
|
|
JP2003530437A
(ja)
*
|
2000-04-13 |
2003-10-14 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
Ａβ４２低下物質
|
|
US20060004086A1
(en)
*
|
2000-04-13 |
2006-01-05 |
Mayo Foundation For Medical Education And Research |
Method of reducing Abeta42 and treating diseases
|
|
WO2002002190A2
(en)
*
|
2000-07-05 |
2002-01-10 |
Johns Hopkins School Of Medicine |
Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes
|
|
US7625951B2
(en)
*
|
2000-07-13 |
2009-12-01 |
University Of Kentucky Research Foundation |
Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals
|
|
WO2002038141A2
(en)
*
|
2000-11-08 |
2002-05-16 |
Massachusetts Institute Of Technology |
Compositions and methods for treatment of mild cognitive impairment
|
|
US8080637B1
(en)
*
|
2001-07-20 |
2011-12-20 |
Kotwal Bioconsulting, LLC |
Therapeutic method of treating brain trauma in rodents with VCP
|
|
CN100586428C
(zh)
*
|
2001-11-02 |
2010-02-03 |
加州大学校务委员会 |
用于预防和治疗炎性疾病,自体免疫性疾病,和移植排斥的组成物及其制药用途
|
|
US8980952B2
(en)
*
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
EP2438913B1
(en)
|
2002-03-20 |
2020-05-06 |
University of Maryland, Baltimore |
A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
|
|
US7977049B2
(en)
*
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
CA2499599A1
(en)
*
|
2002-09-17 |
2004-04-01 |
New York University |
Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors
|
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
|
WO2004035086A2
(en)
*
|
2002-10-16 |
2004-04-29 |
Hunter Samuel F |
Method for treatment of demyelinating central nervous system disease using gm-csf
|
|
US7524515B2
(en)
*
|
2003-01-10 |
2009-04-28 |
Mutual Pharmaceuticals, Inc. |
Pharmaceutical safety dosage forms
|
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
|
EP1603560A1
(en)
*
|
2003-02-06 |
2005-12-14 |
Cipla Ltd. |
Topical immunotherapy and compositions for use therein
|
|
WO2004093816A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
|
|
AT413944B
(de)
*
|
2003-05-27 |
2006-07-15 |
Binder Eva Dkfm |
Verwendung von oxicam-verbindungen
|
|
US20060025337A1
(en)
*
|
2003-07-01 |
2006-02-02 |
President And Fellows Of Harvard College |
Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
|
|
JP2007530417A
(ja)
*
|
2003-07-01 |
2007-11-01 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
細胞及び生物の寿命及びストレス応答を操作するための組成物
|
|
US20050101597A1
(en)
*
|
2003-07-10 |
2005-05-12 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage
|
|
KR20060040676A
(ko)
*
|
2003-07-11 |
2006-05-10 |
미리어드 제네틱스, 인크. |
알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
|
|
US20050192321A1
(en)
*
|
2003-09-15 |
2005-09-01 |
Meythaler Jay M. |
Treatment of neuropathy with rapid release aminopyridine
|
|
MXPA06003663A
(es)
*
|
2003-10-03 |
2006-06-05 |
Pharmacia Corp |
Composiciones de un inhibidor selectivo de la ciclooxigenasa - 2 administrado en condiciones hipotermicas para el tratamiento de trastornos o lesion del sistema nervioso central mediados por isquemicos.
|
|
US20050158376A1
(en)
*
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
US20090169585A1
(en)
*
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US7923448B2
(en)
*
|
2003-11-03 |
2011-04-12 |
Cornell Research Foundation, Inc. |
Purine receptor inhibition as a therapeutic strategy in spinal cord and brain
|
|
BRPI0415939A
(pt)
*
|
2003-11-12 |
2007-01-02 |
Pharmacia & Upjohn Co Llc |
composições de um inibidor seletivo da ciclooxigenase-2 e um agente de modulação do fator neurotrófico para o tratamento de distúrbios mediados pelo sistema nervoso central
|
|
US20050171027A1
(en)
|
2003-12-29 |
2005-08-04 |
President And Fellows Of Harvard College |
Compositions for treating or preventing obesity and insulin resistance disorders
|
|
US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
|
WO2005092062A2
(en)
*
|
2004-03-19 |
2005-10-06 |
Myriad Genetics, Inc. |
Compounds for neurodegenerative disorders
|
|
JP4963670B2
(ja)
*
|
2004-04-07 |
2012-06-27 |
レスベラトロル パートナーズ， エルエルシー |
栄養補助サプリメントおよびそれを処理する方法
|
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
AU2005241023A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
|
US20060084085A1
(en)
*
|
2004-06-16 |
2006-04-20 |
Sinclair David A |
Methods and compositions for modulating Bax-mediated apoptosis
|
|
US20060014705A1
(en)
*
|
2004-06-30 |
2006-01-19 |
Howitz Konrad T |
Compositions and methods for selectively activating human sirtuins
|
|
GB0417401D0
(en)
*
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
US9629838B2
(en)
|
2004-09-16 |
2017-04-25 |
Morehouse School Of Medicine |
Composition for reducing nervous system injury and method of making and use thereof
|
|
EP1802313B1
(en)
*
|
2004-09-18 |
2010-11-03 |
University of Maryland, Baltimore |
Therapeutic agents trageting the ncca-atp channel and methods of use thereof
|
|
JP5085326B2
(ja)
*
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド，ボルチモア |
ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
|
|
US20060154980A1
(en)
*
|
2005-01-11 |
2006-07-13 |
Finley John W |
Improved cox-2 inhibitory compositions and therapeutic regimen
|
|
EP1850840A2
(en)
*
|
2005-01-13 |
2007-11-07 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
|
WO2006138418A2
(en)
*
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
|
CA2615063A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
|
US20070021421A1
(en)
*
|
2005-07-25 |
2007-01-25 |
Hampton Thomas G |
Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis
|
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
|
WO2008006099A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
|
GB0620685D0
(en)
*
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
|
US9511075B2
(en)
*
|
2007-01-12 |
2016-12-06 |
The University Of Maryland, Baltimore |
Targeting NCCA-ATP channel for organ protection following ischemic episode
|
|
US11696908B2
(en)
|
2007-01-31 |
2023-07-11 |
Biosuccess Biotech Co. Ltd. |
Compositions and methods of use of phorbol esters
|
|
US9533938B2
(en)
|
2007-01-31 |
2017-01-03 |
Biosuccess Biotech Co., Ltd. |
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
US9636317B2
(en)
|
2007-01-31 |
2017-05-02 |
Biosuccess Biotech Co. Ltd. |
Compositions and methods of use of phorbol esters
|
|
US9974764B2
(en)
|
2007-01-31 |
2018-05-22 |
Biosuccess Biotech Co. Ltd. |
Compositions and methods of use of phorbol esters in the treatment of neoplasms
|
|
EP2170053A4
(en)
|
2007-01-31 |
2010-06-23 |
Biosuccess Biotech Company |
Compositions and methods of use of phorbol esters
|
|
US10369222B2
(en)
|
2012-01-18 |
2019-08-06 |
Biosuccess Biotech Co., Ltd. |
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
US11564901B2
(en)
|
2007-01-31 |
2023-01-31 |
Biosuccess Biotech Co., Ltd. |
Compositions and methods of use of phorbol esters
|
|
EP2114160B1
(en)
*
|
2007-02-09 |
2016-11-16 |
University of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
GB0702972D0
(en)
*
|
2007-02-15 |
2007-03-28 |
Cambridge Entpr Ltd |
Induction of autography
|
|
CA2691199C
(en)
|
2007-06-22 |
2017-09-12 |
Marc J. Simard |
Inhibitors of ncca-atp channels for therapy
|
|
WO2009104556A1
(ja)
*
|
2008-02-19 |
2009-08-27 |
株式会社岐阜セラツク製造所 |
組成物
|
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
|
GB0911888D0
(en)
*
|
2009-07-08 |
2009-08-19 |
Oxford Biodynamics Ltd |
Method of treating age related disorders
|
|
WO2011047091A1
(en)
*
|
2009-10-13 |
2011-04-21 |
Martek Biosciences Corporation |
Methods for treating traumatic brain injury
|
|
US8916528B2
(en)
|
2011-11-16 |
2014-12-23 |
Resveratrol Partners, Llc |
Compositions containing resveratrol and nucleotides
|
|
US10099996B2
(en)
|
2012-01-18 |
2018-10-16 |
Biosuccess Biotech Co. Ltd. |
Compositions and methods of use of phorbol esters in the treatment of neoplasms
|
|
US9550722B2
(en)
|
2012-01-18 |
2017-01-24 |
Biosuccess Biotech Co. Ltd. |
Compositions and methods of use of phorbal esters for the treatment of stroke
|
|
NZ727304A
(en)
*
|
2012-01-18 |
2018-08-31 |
Biosuccess Biotech Co Ltd |
Compositions and methods of use of phorbol esters for the treatment of stroke
|
|
JP6648007B2
(ja)
*
|
2013-06-13 |
2020-02-14 |
スマートフィッシュ・アーエス |
アルツハイマー病の治療、遅延及び／又は予防において使用するための、レスベラトロール又はその誘導体を含む水産油配合物
|
|
EP2818177A1
(en)
*
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
|
|
US10603316B2
(en)
|
2013-08-21 |
2020-03-31 |
Morehouse School Of Medicine |
Composition and methods for preventing or reducing the incidence of transient ischemic attacks
|
|
JP2016528283A
(ja)
*
|
2013-08-21 |
2016-09-15 |
モアハウス スクール オブ メディスンＭｏｒｅｈｏｕｓｅ Ｓｃｈｏｏｌ Ｏｆ Ｍｅｄｉｃｉｎｅ |
神経系損傷を減少させるための組成物及びその製造方法及び使用
|
|
MA40904A
(fr)
*
|
2014-11-03 |
2017-09-12 |
Hygeia Tech Inc |
Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie
|
|
US11103465B2
(en)
|
2017-11-22 |
2021-08-31 |
Ted's Brain Science, Inc. |
Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
|
|
JP2018138592A
(ja)
*
|
2018-05-08 |
2018-09-06 |
モアハウス スクール オブ メディスンＭｏｒｅｈｏｕｓｅ Ｓｃｈｏｏｌ Ｏｆ Ｍｅｄｉｃｉｎｅ |
神経系損傷を減少させるための組成物及びその製造方法及び使用
|
|
JP2020079289A
(ja)
*
|
2020-02-07 |
2020-05-28 |
モアハウス スクール オブ メディスンＭｏｒｅｈｏｕｓｅ Ｓｃｈｏｏｌ Ｏｆ Ｍｅｄｉｃｉｎｅ |
神経系損傷を減少させるための組成物及びその製造方法及び使用
|